GALMED PHARMACEUTICALS LTD (GLMD) Stock Analyst Ratings
NASDAQ:GLMD - Nasdaq - IL0011313900 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 43% to GLMD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 12.24. This target is 780.58% above the current price.
GLMD was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about GLMD.
In the last month the buy percentage fell by 40 points. So the trust of analysts is decreasing.
GLMD was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-04-04 | Maxim Group | Downgrade | Buy -> Hold |
| 2023-07-24 | Maxim Group | Upgrade | Hold -> Buy |
| 2022-08-08 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2022-08-08 | Maxim Group | Downgrade | Buy -> Hold |
| 2022-05-18 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2022-05-03 | Raymond James | Maintains | Outperform |
| 2022-05-03 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2021-05-17 | Canaccord Genuity | Maintains | Buy |
| 2021-03-19 | HC Wainwright & Co. | Maintains | Buy |